Kernal Biologics Competitors and Similar CompaniesClear all
Legend Biotech's competitors and similar companies include Mersana Therapeutics, Seagen and Dendreon.
 Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
|  Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms. |  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. |  Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy. | |
Founding Date | Founding Date 2014 | Founding Date 2005 | Founding Date 1998 | Founding Date 1992 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | ||||
Locations | Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US | Locations Cambridge, US HQ | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US |
Employees | Employees 2,90012% increase | Employees 11033% increase | Employees 3,25622% increase | Employees 6131% decrease |
Valuation ($) | Valuation ($) 8.4 b | Valuation ($) 250.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $1b (FY, 2025) | Revenue (est.) $40.5m (FY, 2024) | Revenue (est.) $2b (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods $408.1m (FY, 2025) | Cost of goods N/A | Cost of goods $410.1m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit $620.8m (FY, 2025) | Gross profit N/A | Gross profit $1.6b (FY, 2022) | Gross profit N/A |
Net income | Net income ($296.8m) (FY, 2025) | Net income ($69.2m) (FY, 2024) | Net income ($610.3m) (FY, 2022) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 150.5m | Total funding raised $ 219.5m | Total funding raised $ 164m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Mersana Therapeutics
HQ
Cambridge, US
Employees
110↑ 33% increase
Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.
View companySeagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View companyDendreon
HQ
Seal Beach, US
Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.
View company